Compare RLAY & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | AHCO |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2020 | 2017 |
| Metric | RLAY | AHCO |
|---|---|---|
| Price | $9.59 | $11.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $16.86 | $13.25 |
| AVG Volume (30 Days) | ★ 2.5M | 1.4M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,355,000.00 | ★ $3,244,857,000.00 |
| Revenue This Year | N/A | $9.00 |
| Revenue Next Year | $324.03 | $6.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $1.78 | $7.11 |
| 52 Week High | $11.49 | $11.75 |
| Indicator | RLAY | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 61.06 |
| Support Level | $9.06 | $8.69 |
| Resistance Level | $11.46 | N/A |
| Average True Range (ATR) | 0.63 | 0.48 |
| MACD | -0.12 | 0.16 |
| Stochastic Oscillator | 16.18 | 71.36 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.